Researchers from the Institute for Advanced Chemistry of Catalonia (IQAC) of the Spanish National Research Council (CSIC) ...

Most patients receiving a GLP-1 receptor agonist (RA) and a biologic continue co-therapy for over a year with few treatment-related adverse events.

Biologic drugs for asthma may be initiated or continued while conceiving or during pregnancy or breastfeeding following appropriate risk-benefit discussions and shared decision-making, a consensus ...

Pyrroloquinoline quinone (PQQ) is a redox-active quinone that has garnered considerable attention for its diverse biological roles. Originally identified as a bacterial cofactor, PQQ has emerged as a ...